Amlitude Surgical (1AU.SG)
| Previous close | 3.0300 |
| Open | 3.0400 |
| Bid | 3.0100 x 0 |
| Ask | 3.1200 x 0 |
| Day's range | 3.0000 - 3.0400 |
| 52-week range | 2.3800 - 3.2800 |
| Volume | |
| Avg. volume | 9 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amplitude Surgical Announces Its Results for the First Half of 2022-23: Sales of €45.2 Million and EBITDA of €11.7 Million
VALENCE, France, March 22, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its results for the first half of its 2022-23 financial year.
- Business Wire
Amplitude Surgical – H1 2022-23: Consolidated Sales of €45.2 Million, +10.8% at Constant Exchange Rates
VALENCE, France, February 23, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first half of its 2022-23 financial year.
- Business Wire
Amplitude Surgical – First Quarter 2022-23: Consolidated Sales of €19.4 Million, +11.3% at Constant Exchange Rates
VALENCE, France, November 24, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first quarter of its 2022-23 financial year.
